Shamaila Aslam
Internal Medicine · Tomball, TXNPI 1992748545
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (47.0%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Eli Lilly at 37.1% of the total. Reporting peaked in 2019 at $4,649 and has fallen 94.9% since, to $239 in 2025. Among internal medicine clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 85 payments — averaging $123.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly$4K
- Eli Lilly Export S.A. Puerto Rico Branch$4K
- Novartis$1K
- Janssen Research & Development, LLC$944
- Endologix LLC$241
- Amgen$116
- plus $338 from 10 others
Across 521 payments — averaging $14,400 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$2.2M
- Novartis$2.1M
- Janssen Research & Development, LLC$1M
- AbbVie$816K
- Pfizer$758K
- Amgen$412K
- plus $251K from 7 others
What the payments were for
- Consulting fees$3,50033%
- Travel & lodging$4,93747%
- Food & beverage$2,06920%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eli Lilly | 36 | $3,894 |
| Eli Lilly Export S.A. Puerto Rico Branch | 3 | $3,580 |
| Novartis | 11 | $1,393 |
| Janssen Research & Development, LLC | 8 | $944 |
| Endologix LLC | 1 | $241 |
| Amgen | 8 | $116 |
| Johnson & Johnson | 5 | $90 |
| Merck | 3 | $51 |
| Edwards Lifesciences | 2 | $48 |
| Novo Nordisk | 2 | $41 |
| Esperion Therapeutics, Inc. | 1 | $23 |
| Actelion Pharmaceuticals US, Inc. | 1 | $22 |
| Amarin Pharma, Inc. | 1 | $17 |
| Sanofi-aventis U.S. LLC | 1 | $16 |
| Irhythm Technologies, Inc. | 1 | $16 |
| Boston Scientific | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,506 in reported general payments places this provider in the 95th percentile of 7,675 internal medicine providers in Texas.
Other internal medicine in Tomball
- Spencer BerthelsenSugar Land$891K
- Hameed AliTemple$773K
- Marc TribbleDallas$693K
- Gary SinclairDallas$599K
- Mohammed Al-NajjarEl Paso$586K
- Han SchmidlyDallas$465K
- Hussein TawbiHouston$365K
- Hans LeeHouston$327K
- Tapan KadiaHouston$311K
- Nitin JainHouston$281K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.